Evidence map›Paper›PMID 41669620›Full record

ArticleCanadian journal of pain = Revue canadienne de la douleur2026

Substance use frequency and associations with chronic pain among a cohort of people who inject drugs in Montreal, Canada.

Sasha Udhesister, Sarah Larney, M Gabrielle Pagé, Nanor Minoyan, Stine Bordier Høj, Valérie Martel-Laferrière, Didier Jutras-Aswad, Julie Bruneau

Abstract read
In one paragraph

Article in Canadian journal of pain = Revue canadienne de la douleur, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sasha UdhesisterCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Canada.
Sarah LarneyCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Canada.ORCID https://orcid.org/0000-0002-5602-4963
M Gabrielle PagéCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Canada.ORCID https://orcid.org/0000-0002-7742-2717
Nanor MinoyanCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Canada.ORCID https://orcid.org/0000-0002-0470-0720
Stine Bordier HøjCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Canada.ORCID https://orcid.org/0000-0002-5403-8341
Valérie Martel-LaferrièreCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Canada.ORCID https://orcid.org/0000-0001-7973-8582
Didier Jutras-AswadCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Canada.ORCID https://orcid.org/0000-0002-8474-508X
Julie BruneauCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Canada.ORCID https://orcid.org/0000-0002-3484-6456

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The relationship between substance use and chronic pain is bidirectional. Although chronic pain and polysubstance use are highly prevalent among people who inject drugs (PWID), few studies have examined how the frequency of use of different substances relates to chronic pain. Aims: The aim of this study was to examine associations between substance use frequency and chronic pain in a sample of PWID. Methods: A cross-sectional analysis was conducted among PWID participating in a community-based cohort in Montreal, Canada. Chronic pain measures were introduced in the interviewer-administered questionnaire in February 2017. The first questionnaire was used for analyses, which covers data up to November 2022. Logistic regression analyses were conducted to examine associations between alcohol, stimulants, opioid and cannabis frequency and chronic pain. Results: Six hundred and eight participants were included; 84% were men and mean age was 44.7 years old. Prevalence of chronic pain was 48%. Age (adjusted odds ratio [aOR] = 1.38, 95% confidence interval [CI] 1.15-1.65) and regular alcohol consumption in the past month (aOR = 1.76, 95% CI 1.13-2.75) were associated with chronic pain in univariable and multivariable logistic regression models. The frequency of use for all other substances was not found to be significantly associated with chronic pain. Conclusion: The prevalence of chronic pain in our sample was high. The positive association between high frequency of alcohol use and chronic pain could be explained by alterations of pain pathways by heavy use and withdrawal episodes, potentially increasing hyperalgesia. This study underscores the importance of addressing alcohol use along with other substances among PWID.

Indexed as

alcohol useChronic painpeople who inject drugssubstance use

Identifiers

PMID41669620
PMCPMC12885412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.